GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medprin Regenerative Medical Technologies Co Ltd (SZSE:301033) » Definitions » Total Assets

Medprin Regenerative Medical Technologies Co (SZSE:301033) Total Assets : ¥744.5 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medprin Regenerative Medical Technologies Co Total Assets?

Medprin Regenerative Medical Technologies Co's Total Assets for the quarter that ended in Sep. 2024 was ¥744.5 Mil.

Warning Sign:

If a company builds assets at 43.8% a year, faster than its revenue growth rate of 11.8% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Medprin Regenerative Medical Technologies Co's average Total Assets Growth Rate was 0.50% per year. During the past 3 years, the average Total Assets Growth Rate was 32.40% per year. During the past 5 years, the average Total Assets Growth Rate was 43.80% per year.

During the past 7 years, Medprin Regenerative Medical Technologies Co's highest 3-Year average Total Assets Growth Rate was 52.40%. The lowest was 32.40%. And the median was 42.55%.

Total Assets is connected with ROA %. Medprin Regenerative Medical Technologies Co's annualized ROA % for the quarter that ended in Sep. 2024 was 11.23%. Total Assets is also linked to Revenue through Asset Turnover. Medprin Regenerative Medical Technologies Co's Asset Turnover for the quarter that ended in Sep. 2024 was 0.09.


Medprin Regenerative Medical Technologies Co Total Assets Historical Data

The historical data trend for Medprin Regenerative Medical Technologies Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medprin Regenerative Medical Technologies Co Total Assets Chart

Medprin Regenerative Medical Technologies Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial 340.05 455.34 746.79 744.92 786.97

Medprin Regenerative Medical Technologies Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 756.42 786.97 778.04 709.81 744.47

Medprin Regenerative Medical Technologies Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Medprin Regenerative Medical Technologies Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=635.858+151.111
=787.0

Medprin Regenerative Medical Technologies Co's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=663.27+81.204
=744.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medprin Regenerative Medical Technologies Co  (SZSE:301033) Total Assets Explanation

Total Assets is connected with ROA %.

Medprin Regenerative Medical Technologies Co's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=81.648/( (709.81+744.473)/ 2 )
=81.648/727.1415
=11.23 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Medprin Regenerative Medical Technologies Co's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=68.894/( (709.81+744.473)/ 2 )
=68.894/727.1415
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Medprin Regenerative Medical Technologies Co Total Assets Related Terms

Thank you for viewing the detailed overview of Medprin Regenerative Medical Technologies Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Medprin Regenerative Medical Technologies Co Business Description

Traded in Other Exchanges
N/A
Address
No. 80 Lanyue Road, 3rd Floor, Area E, High-tech Industrial Development Zone, Guangdong Province, Science City, Guangzhou, CHN, 510700
Medprin Regenerative Medical Technologies Co Ltd is engaged in the development and manufacturing of high-performance implanted medical devices.
Executives
Wang Jian Hua Directors, executives
Yuan Yu Yu Directors, executives
Yuan Mei Fu Director
Luo Ya Hong Directors, executives
Long Xiao Yan Secretary, Director

Medprin Regenerative Medical Technologies Co Headlines

No Headlines